In accordance with Section 287(a) of Title 35 of the United States Code, notice is hereby given of the US patent covering TARPEYO™ (budesonide), delayed release capsules.

TARPEYO™ (budesonide), delayed release capsules, is covered by US patent 8,491,932.

The patent information displayed on this page is believed to be accurate as of the most recent update* of the page but should not be considered exhaustive. In particular, omission of a particular patent from this page is not an admission or representation that that patent does not cover TARPEYO™ (budesonide), delayed release capsules, and/or one or more of its components.

*01/2022